Children's Hospital Los Angeles

What Is Kawasaki Disease?

Kawasaki disease: the basics, its symptoms and treatment.

Kawasaki disease, sometimes called Kawasaki syndrome, is a serious inflammation of the blood vessels  which affects young children, often under 5 years of age. Marked by fever, swelling and other symptoms, it can lead to coronary artery aneurysms in approximately 25% of cases if untreated. It is only diagnosable based on clinical signs and symptoms, unlike many other diseases that are diagnosed with laboratory results such as blood test or culture from a swab, and is the leading cause of acquired heart disease in children in developed countries. 

A COVID-19 connection 

You may have heard about a relationship between Kawasaki disease and the COVID-19 pandemic. In some cases, patients with Kawasaki disease-like symptoms have tested positive for having had a previous coronavirus infection. When a child has a confirmed case of past novel coronavirus infection (as diagnosed by a serology test for antibodies or a previous COVID-19 positive test), he or she may receive a diagnosis of multisystem inflammatory syndrome in children, or MIS-C (previously referred to as pediatric inflammatory multisystem syndrome  or PIMS). MIS-C and Kawasaki disease share many similarities, but MIS-C can range from symptoms Kawasaki disease-like to even more severe conditions, like toxic shock syndrome.  

What is Kawasaki disease? 

Kawasaki disease is a rare condition affecting less than 0.02% of children in the United States. The disease is marked by signs of inflammation such as fever, rash, swelling and redness. There is no known cause for Kawasaki disease. Timely treatment of the disorder greatly reduces the incidence of coronary artery aneurysm, from 25% to around 4%. Some of the vessels around the heart may dilate or get larger. Your pediatrician will treat suspected Kawasaki disease immediately to decrease the severity of these complications. Without treatment, the dilated blood vessels may form aneurysms, which could lead to blood clots and blocked blood flow to the heart (heart attack). In many cases, blood vessels will return to normal size in time, following proper treatment. 

Is Kawasaki disease contagious? 

No, Kawasaki disease is not contagious. The cause of the disease is unknown. If a child has been infected with the coronavirus and later shows symptoms consistent with Kawasaki disease, he or she will likely be given a serology test, which looks for antibodies demonstrating a past COVID-19 infection. If positive, patients may be diagnosed with the related condition of multisystem inflammatory syndrome in children, or MIS-C.  

What are the symptoms of Kawasaki disease? 

If your child’s doctor suspects Kawasaki disease, he or she will assess your child’s symptoms to make a diagnosis. Most or all of the following symptoms must be present for a child to be diagnosed: 

  • Persistent fever (5 days or more) 
  • Rash 
  • Redness in whites of the eyes 
  • Redness in lips or tongue 
  • Redness/swelling in hands and or feet 
  • Swollen lymph nodes of the neck 

If only a few of the symptoms are present without other explanation, your child’s care team may order laboratory tests to aid in diagnosis.  

What should I do if I think my child has Kawasaki disease? 

If you think that your child has Kawasaki disease or MIS-C, you should contact your child’s doctor or pediatrician immediately. Specialty hospitals like Children’s Hospital Los Angeles are sharing their findings with pediatricians in the community so they know what to look for when screening patients. Families are likely to be able to obtain an initial screening quickly by contacting their pediatrician. At Children’s Hospital Los Angeles (CHLA), a clinical team is devoted to finding out more information about MIS-C and is working to develop and release timely information to pediatricians who are members of the CHLA Health Network. 

Families with a child experiencing serious illness should not delay in getting care and should immediately seek attention from their nearest emergency room. 

How is Kawasaki disease treated? 

Children’s Hospital Los Angeles has been a leader in the treatment of Kawasaki disease and continues to offer the expertise and care of a dedicated team that specializes in the disorder. Specialists will work together to ensure your child is given the best available treatment. At CHLA, experts from the Divisions of Cardiology and Infectious Diseases will form a clinical care team for your child to devise a care plan. One of the treatments for Kawasaki disease is an intravenous infusion of immunoglobulin (also called IVIG). This mix of antibodies will support your child’s immune system and decrease inflammation. Often, this treatment is effective in Kawasaki disease. Other treatments include anticoagulants, anti-inflammatory medication, or other medications that affect the immune system. 

What happens when my child is discharged after treatment for Kawasaki disease? 

After your child is discharged from the hospital, your care team will want to see your child for a two-week follow up. Another appointment will be scheduled several weeks after the initial follow-up. Though rare, a child can experience return of symptoms such as fever or rash in the weeks after discharge. It is important to follow the instructions given to your family by your care team.

Symptoms used to diagnose Kawasaki disease

Children with many or all of the following symptoms may have Kawasaki disease:

  1. Persistent fever (5 days or more)
  2. Rash
  3. Redness in whites of they eyes
  4. Redness in lips or tongue
  5. Redness/swelling in hands or feet
  6. Swollen lymph nodes of the neck


Filters close

Showing results

110 of 2776
Newswise:Video Embedded protocol-needed-to-monitor-covid-19-disease-course
Released: 3-Aug-2020 9:05 PM EDT
Protocol needed to monitor COVID-19 disease course
University of Washington School of Medicine and UW Medicine

Patients with underlying conditions such as asthma or other lung problems should be checked on regularly by pulmonologists or primary-care doctors for at least six months. Some will need to be monitored for one to three years, according to a new opinion piece posted online today in The Lancet-Respiratory Medicine.

Newswise: UM Cardiology Researchers Studying How COVID-19 Affects the Heart
Released: 3-Aug-2020 3:10 PM EDT
UM Cardiology Researchers Studying How COVID-19 Affects the Heart
University of Miami Health System, Miller School of Medicine

COVID-19 is shown to impact the heart and, in some cases, have long-lasting cardiac effects. To discover the extent to which COVID-19 affects the heart, cardiologists and researchers with the University of Miami Miller School of Medicine have begun multiple studies.

Newswise: Tackling the Bioethics Challenges Raised by COVID-19
Released: 3-Aug-2020 3:05 PM EDT
Tackling the Bioethics Challenges Raised by COVID-19
University of Pennsylvania School of Nursing

The diverse situations experienced by health-care workers during the COVID-19 pandemic often present serious ethical challenges. From the allocation of resources and triage protocols to health-care worker and patient rights and the management of clinical trials, new ethical questions have come to the forefront of today’s global public health emergency.

Newswise: 239156_web.jpg
Released: 3-Aug-2020 2:50 PM EDT
New species of fungus sticking out of beetles named after the COVID-19 quarantine
Pensoft Publishers

A major comprehensive study on Herpomycetales and Laboulbeniales, two orders of unique ectoparasitic fungi associated with insects and other arthropods (class Laboulbeniomycetes) in Belgium and the Netherlands was published in the open-access, peer-reviewed scholarly journal MycoKeys.

Released: 3-Aug-2020 1:30 PM EDT
Consumer Behavior Has Shifted Significantly During Pandemic, Survey Reveals
Rensselaer Polytechnic Institute (RPI)

The COVID-19 pandemic has brought about an increase in telework and online commerce, and a significant decrease in the number of personal trips people are making. Understanding the effects of these rapid changes on the economy, supply chains, and the environment will be essential, as some of these behaviors will continue even after the pandemic has ended. Researchers from Rensselaer Polytechnic Institute recently presented the results of two sets of surveys they conducted in an effort to quantify and understand these unprecedented shifts.

access_time Embargo lifts in 2 days
Embargo will expire: 5-Aug-2020 12:05 AM EDT Released to reporters: 3-Aug-2020 12:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 5-Aug-2020 12:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

31-Jul-2020 4:05 PM EDT
The effects of COVID-19 on emergency visits, hospitalizations
Mayo Clinic

COVID-19 swept into the U.S., hospitals across the country have reported that their emergency departments are emptying out. In a new study published Monday, Aug. 3, in JAMA Internal Medicine, a team of researchers from multiple institutions provides insights into this phenomenon.

Newswise: Important Dementia Studies Continuing at UK Despite Ongoing COVID-19 Pandemic
Released: 3-Aug-2020 10:20 AM EDT
Important Dementia Studies Continuing at UK Despite Ongoing COVID-19 Pandemic
University of Kentucky

The COVID-19 pandemic brought many things to a screeching halt and continues to impact our daily lives. However, important research at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) is continuing under extreme caution and deep dedication. A monumental study in the field of dementia research is set to get underway in the coming weeks at UK.

Showing results

110 of 2776